Serological test: |
With classical symptoms: |
Positive serology supports a diagnosis of CD, but they are not |
Tissue transglutaminase antibody (tTGA) |
Serological test: |
essential. Compatible with HLA-DQ2/D8 testing and identify |
Endomysial antibody (EMA) |
Tissue transglutaminase antibody (tTGA) |
individuals for further biopsy evaluation. Small bowel biopsy |
Gliadin antibodies (AGA) |
Endomysial antibody (EMA) |
is critical in symptomatic patients with negative serology for |
Total IgA |
Gliadin antibodies (AGA) |
CD and with HLA compatible with the disease |
Endoscopy |
HLA-DQ2/DQ8 testing |
Determination of HLA typing as a first step in diagnosis in CD family |
|
Capsule endoscopy (with adequate pathological interpretation) |
Adequate number of biopsies and well oriented. Estimate lymphocyte infiltration and partial or total villus atrophy |
|
Without classical symptoms HLA-DQ2/DQ8 testing |
Primordial role of HLA-typing if serology is negative and with biopsy refused or equivocal to identify individuals |
|
Serologic test: |
Adequate number of biopsies and well oriented. Estimate |
Tissue transglutaminase antibody (tTGA) |
lymphocyte infiltration and partial or total villous atrophy |
Endomysial antibody (EMA) |
|
Gliadin antibodies (AGA) |
|
Capsule endoscopy (with adequate pathological interpretation) |